Leipzig's Bayesian network matched tumor board decisions 95.1% of the time, and an audit of its own tables explains why.
An AI-scored liquid biopsy from City of Hope caught stage 1 and 2 pancreatic cancer 87% of the time in…
Massive Bio has appointed a Seoul-based partner to grow its AI clinical trial matching business in Korea, where it has…
The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
A multimodal assistant answers clinical questions about whole gigapixel pathology slides instead of small tissue crops.
A pathology AI trained only on frozen sections matched real surgical decisions in a prospective cohort of more than 3,000…
Cureety acquires Reimagine Care, pairing AI-driven triage with oncology clinical teams across 250 centers.
Boehringer Ingelheim licenses Owkin's K Pro AI scientist and multimodal oncology and immunology data.